… In conclusion, model-based economic evaluations on dabigatran vs. VKAs for the … Economic
evaluation of dabigatran etexilate in the management of atrial fibrillation in Greece. Hellenic …

… in patients with atrial fibrillation: a Greek perspective. Am J Cardiovasc Drugs. 2017;17(2):123-33. …
This model is used for economic evaluations in healthcare systems, considering the …

… . Economic evaluation of dabigatran etexilate in the management of atrial fibrillation in
Greece. Hellenic J Cardiol 2013;54:289–300.pmid:http://www.ncbi.nlm.nih.gov/pubmed/…

… Last but not least, the economic impact of drug administration in Greece of economic crisis is
major. In a study of Andrikopoulos et al. … Economic Evaluation of Dabigatran Etexilate in the …

… analysis, the same distribution of DOAC use was assumed. Daily doses of dabigatran
etexilate … (For elaboration of the estimation of costs associated with PSM and DOAC treatment, …

… for economic evaluations [… Economic Evaluation Reporting Standards statement provides
a list of 24 items and accompanying recommendations for reporting economic evaluations (…

… atrial fibrillation OR atrial fibrillation AND nonvitamin-K-antagonists OR new oral anticoagulants
OR novel oral anticoagulants OR dabigatran OR … in this meta-analysis that was not pre-…

… This study aims to review the existing economic evaluations of novel oral anticoagulants (…
This study highlights the economic evaluation methodology of NOACs in patients with AF …

… were atrial fibrillation (59 patients) … economic analysis are based on network meta-analysis
(NMAs), which analyse available direct and indirect evidence to estimate relative treatment …

… extracted from a sub-analysis of the Greek pilots of the ESC … this analysis was to develop
a health-economic evaluation in … cost-effectiveness dabigatran etexilate versus warfarin for …